Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Return on Invested Capital (2025)

Historic Return on Invested Capital for Connect Biopharma Holdings (CNTB) over the last 1 years, with Q3 2025 value amounting to 0.83%.

  • Connect Biopharma Holdings' Return on Invested Capital changed N/A to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year change of. This contributed to the annual value of 0.24% for FY2024, which is N/A changed from last year.
  • Per Connect Biopharma Holdings' latest filing, its Return on Invested Capital stood at 0.83% for Q3 2025.
  • Connect Biopharma Holdings' Return on Invested Capital's 5-year high stood at 0.25% during Q1 2025, with a 5-year trough of 0.83% in Q3 2025.